Telesis Bio, Inc. (TBIO)
NASDAQ: TBIO · IEX Real-Time Price · USD
4.100
+0.190 (4.86%)
At close: Jul 26, 2024, 3:57 PM
3.980
-0.120 (-2.93%)
After-hours: Jul 26, 2024, 4:00 PM EDT
Telesis Bio Market Cap
Telesis Bio has a market cap or net worth of $6.86 million as of July 26, 2024. Its market cap has decreased by -86.58% in one year.
Market Cap
6.86M
Enterprise Value
27.26M
1-Year Change
-86.58%
Ranking
Category
Stock Price
$4.10
Market Cap Chart
Since the IPO on June 18, 2021, Telesis Bio's market cap has decreased from $451.66M to $6.86M, a decrease of -98.48%. That is a compound annual growth rate of -74.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 6.60M | -45.00% |
| Dec 29, 2023 | 12.00M | -66.10% |
| Dec 30, 2022 | 35.40M | -88.82% |
| Dec 31, 2021 | 316.50M | -29.93% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeuroMetrix | 7.24M |
| Chromocell Therapeutics | 7.24M |
| Pulmatrix | 7.20M |
| Shuttle Pharmaceuticals Holdings | 7.15M |
| Sonoma Pharmaceuticals | 7.12M |
| Notable Labs | 6.77M |
| Virios Therapeutics | 6.76M |
| Xenetic Biosciences | 6.55M |